One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...

China's newly approved and domestically developed 9-valent human papillomavirus vaccine is expected to give potential recipients more access to the cancer-preventing shot. This makes China the second ...

A new study suggests recommending the vaccine at ages 9-10 years is not only practical for clinics but could increase uptake ...

The UK Health Security Agency (UKHSA) has warned that variations in geographical coverage of Human Papillomavirus (HPV) ...

Discover why HPV vaccination rates lag behind despite preventing cervical cancer. Learn the facts about this life-saving ...

The UK Health Security Agency (UKHSA) has revealed that low vaccine uptake among children is leaving many women vulnerable to ...

A recent report has highlighted the concerning decline in uptake of a vaccine that could significantly increase chances of ...

YOUNG women are at higher risk of a “preventable” cancer due to “alarmingly” low uptake of life-saving NHS jabs, health chiefs have warned. Human papillomavirus (HPV) ...

The latest available data from PHS shows the average HPV vaccination coverage among S1 pupils last year was 71.5%, down from ...

Recent government figures have shown the drop in HPV vaccines among young people is only continuing. This is despite the fact ...

The month-long campaign will appear on television, radio, online and in public signage around the five boroughs.

Diseases caused by human papillomavirus (HPV), such as cervical cancer, may have a new treatment option thanks to a technology developed by researchers at Imunotera Soluções Terapêuticas, a São Paulo ...